摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydro-2-isoquinolinio]propyl-1-sulfate | 213999-54-3

中文名称
——
中文别名
——
英文名称
3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydro-2-isoquinolinio]propyl-1-sulfate
英文别名
3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl sulfate
3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydro-2-isoquinolinio]propyl-1-sulfate化学式
CAS
213999-54-3
化学式
C24H33NO9S
mdl
——
分子量
511.593
InChiKey
LJRQIWQSSFHPKA-ZCYQVOJMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    35
  • 可旋转键数:
    10
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    121
  • 氢给体数:
    0
  • 氢受体数:
    9

反应信息

  • 作为反应物:
    描述:
    3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydro-2-isoquinolinio]propyl-1-sulfate甲醇乙酰氯 作用下, 反应 6.0h, 以98%的产率得到(1S,2R)-6,7-dimethoxy-2-(3-hydroxypropyl)-2-methyl-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydroisoquinolinium chloride
    参考文献:
    名称:
    Synthesis of Ultra-Short-Acting Neuromuscular Blocker GW 0430:  A Remarkably Stereo- and Regioselective Synthesis of Mixed Tetrahydroisoquinolinium Chlorofumarates
    摘要:
    [GRAPHICS]The stereo- and regioselective synthesis of ultra-short-acting nondepolarizing neuromuscular blocker GW 0430 (5a) is described. Key steps involved the enantioselective transfer hydrogenation of imine 8 employing Noyori's catalyst, the stereoselective crystallization and methanolysis of trans-betaines 11 and 12, and the stereo- and regioselective trans elimination of hydrogen chloride from 14, The latter transformation allowed complete control of the position of the chloro substituent and stereochemistry at the double bond of the linker in 15.
    DOI:
    10.1021/ol9911573
  • 作为产物:
    描述:
    (1S)-6,7-dimethoxy-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydroisoquinolinium formate 在 甲酸 作用下, 以 乙腈 为溶剂, 反应 7.0h, 生成 3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydro-2-isoquinolinio]propyl-1-sulfate
    参考文献:
    名称:
    Synthesis of Ultra-Short-Acting Neuromuscular Blocker GW 0430:  A Remarkably Stereo- and Regioselective Synthesis of Mixed Tetrahydroisoquinolinium Chlorofumarates
    摘要:
    [GRAPHICS]The stereo- and regioselective synthesis of ultra-short-acting nondepolarizing neuromuscular blocker GW 0430 (5a) is described. Key steps involved the enantioselective transfer hydrogenation of imine 8 employing Noyori's catalyst, the stereoselective crystallization and methanolysis of trans-betaines 11 and 12, and the stereo- and regioselective trans elimination of hydrogen chloride from 14, The latter transformation allowed complete control of the position of the chloro substituent and stereochemistry at the double bond of the linker in 15.
    DOI:
    10.1021/ol9911573
点击查看最新优质反应信息

文献信息

  • Org Lett. 1999, 1, 1993-1996
    作者:
    DOI:——
    日期:——
  • Synthesis of Ultra-Short-Acting Neuromuscular Blocker GW 0430:  A Remarkably Stereo- and Regioselective Synthesis of Mixed Tetrahydroisoquinolinium Chlorofumarates
    作者:Vicente Samano、John A. Ray、James B. Thompson、Robert A. Mook、David K. Jung、Cecilia S. Koble、Michael T. Martin、Eric C. Bigham、Craig S. Regitz、Paul L. Feldman、Eric E. Boros
    DOI:10.1021/ol9911573
    日期:1999.12.1
    [GRAPHICS]The stereo- and regioselective synthesis of ultra-short-acting nondepolarizing neuromuscular blocker GW 0430 (5a) is described. Key steps involved the enantioselective transfer hydrogenation of imine 8 employing Noyori's catalyst, the stereoselective crystallization and methanolysis of trans-betaines 11 and 12, and the stereo- and regioselective trans elimination of hydrogen chloride from 14, The latter transformation allowed complete control of the position of the chloro substituent and stereochemistry at the double bond of the linker in 15.
查看更多